Autopsy report · NCT04898985
The Leukemia and Lymphoma Society (LLS) T-cells in Blood Cancer and COVID-19
Cause of deathStaffing, sites or logistics
“Recruitment was completed for initial evaluation of T-cell response to early Covid-19”
Life of this trial
- Suspended: paused, and may or may not restart.
- 1,000 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Sponsor
- Larry Saltzman, MD
- Sponsor type
- University, hospital or other
- Conditions
- Covid-19
- Interventions
- ImmunoSEQ
- Participants
- 1,000 (planned, not actual)
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Safety and Efficacy of Vibro-tactile Feedback for Patients Who Underwent Lower Limb Amputation
“recruitment rate of patients was not sufficient during COVID-19; problems with the quality of the primary outcome data collected” - Study Assessing Vagus Nerve Stimulation in CoViD-19 Respiratory Symptoms
“A total of 21 patients were enrolled in the study resulting in 97 total collected specimen time points. Patient recruitment was halted due to greatly decreased numbers of patient hospitalizations for Covid-19.” - A Study of Orally Administered JBPOS0101 in Refractory Infantile Spasms Patients
“Difficulty with patient recruitment due to COVID-19” - Piloting Conversation Cards for Adolescents
“Ongoing COVID-19 restrictions and very low (in-person) clinical activity prevented participant recruitment.” - Iron Isomaltoside Compared With Iron Sucrosein Peritoneal Dialysis Patients
“Difficult patient recruitment due to COVID-19 epidemic”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.